Literature DB >> 30091506

Mentalization-based treatment and its evidence-base status: A systematic literature review.

Javier Malda-Castillo1, Claire Browne2, Guillermo Perez-Algorta1.   

Abstract

PURPOSE: This study reviewed the evidence-base status of mentalization-based treatment (MBT), its quality, strengths, and limitations. The aim was to pave the way for further MBT research.
METHOD: An electronic database and reference lists search identified MBT outcome papers, and these were systematically reviewed. The quality of the studies and the risk of bias were determined using two validated checklist tools.
RESULTS: Twenty-three studies were included in the review. This included nine randomized controlled trials, seven uncontrolled pre- and post-effectiveness studies, three retrospective cohort studies, two uncontrolled randomized trials, and two case studies. The methodological quality of almost half of the papers was assessed as fair (43%), followed by good (34%), poor (17%), and excellent (4%) ratings. Nevertheless, the review identified risk of confounding bias across the majority of studies (60%) and fidelity to treatment was poorly reported in almost half of the studies (47%). Most of the studies focused on borderline personality disorder (BPD), showing positive clinical outcomes for this population but the evidence-base for other presentations was still developing. The treatment of adolescents who self-harm and at-risk mothers in substance abuse treatment showed particularly promising results, as these are client groups that have previously shown limited positive response to psychological interventions.
CONCLUSIONS: Mentalization-based treatment is a potentially effective method across a wide range of clinical presentations but further research should focus on increasing the quality and the quantity of the MBT evidence outside the treatment of BPD. PRACTITIONER POINTS: MBT can be a particularly effective intervention for the treatment of adults with a diagnosis of BPD and of adolescents who self-harm and mothers enrolled in substance abuse treatments. MBT can be an effective intervention for depression and eating disorders but the evidence is currently limited. Professionals supporting mothers of children at risk may benefit from receiving training in the principles of MBT.
© 2018 The British Psychological Society.

Entities:  

Keywords:  literature; mentalisation; mentalization-based treatment; research; review; treatment

Year:  2018        PMID: 30091506     DOI: 10.1111/papt.12195

Source DB:  PubMed          Journal:  Psychol Psychother        ISSN: 1476-0835            Impact factor:   3.915


  5 in total

1.  Mentalization Impairment Is Associated with Problematic Alcohol Use in a Sample of Young Adults: A Cross-Sectional Study.

Authors:  Claudio Imperatori; Ornella Corazza; Angelo Panno; Raffaella Rinaldi; Massimo Pasquini; Benedetto Farina; Massimo Biondi; Francesco Saverio Bersani
Journal:  Int J Environ Res Public Health       Date:  2020-11-22       Impact factor: 3.390

2.  What Bias Management Can Learn From Change Management? Utilizing Change Framework to Review and Explore Bias Strategies.

Authors:  Mai Nguyen-Phuong-Mai
Journal:  Front Psychol       Date:  2021-12-15

3.  Editorial: Misunderstanding Others: Theory of Mind in Psychological Disorders.

Authors:  Manuel Sprung; Juliane Burghardt; Monica Mazza; Friedrich Riffer
Journal:  Front Psychol       Date:  2022-02-07

4.  Do attachment-related differences in reflective functioning explain associations between expressed emotion and youth self-harm?

Authors:  Jamie Kennedy-Turner; Vilas Sawrikar; Lucy Clark; Helen Griffiths
Journal:  Curr Psychol       Date:  2022-08-26

5.  Modular-based psychotherapy (MoBa) versus cognitive-behavioural therapy (CBT) for patients with depression, comorbidities and a history of childhood maltreatment: study protocol for a randomised controlled feasibility trial.

Authors:  Moritz Elsaesser; Sabine Herpertz; Hannah Piosczyk; Carolin Jenkner; Martin Hautzinger; Elisabeth Schramm
Journal:  BMJ Open       Date:  2022-07-12       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.